Overview: Faslodex 250 mg/5 ml (Fulvestrant)
Faslodex 250 mg/5 ml, containing the active ingredient Fulvestrant, is a specialized oncology medication developed by AstraZeneca. It is classified as an estrogen receptor antagonist, scientifically engineered to block the signaling pathways that allow specific types of hormone-sensitive cancer cells to grow.
Mechanism and Clinical Utility
Faslodex functions by binding to the estrogen receptor, which leads to the degradation of the receptor. By reducing the number of estrogen receptors, Faslodex effectively inhibits the growth-promoting effects of estrogen on cancer cells. This targeted approach is essential for patients managing specific malignancies.
Key Therapeutic Benefits
- Estrogen Receptor Degradation: Highly specific action that targets and degrades estrogen receptors to control tumor growth.
- Advanced Oncology Support: Designed as a targeted therapy, offering a precise approach to managing malignancies.
- Clinical Reliability: Developed by AstraZeneca, ensuring high standards of therapeutic efficacy.
- Precise Dosing: Provided as two pre-filled syringes (5 ml each) per pack, with both syringes required to be administered to receive the recommended monthly 500 mg dose.
Product Details and Usage
Faslodex 250 mg/5 ml is provided in a pack containing 2 pre-filled syringes and 2 safety needles. This presentation is designed to support the specific dosing schedules required for effective long-term oncology management.
Safety and Storage Guidelines
Administration: Intramuscular use only. Must be administered strictly as prescribed by your oncologist. Adjustments to therapy or dosing must be performed only by authorized medical professionals.
Storage: Store the syringes in their original packaging in a cool, dry place. Keep out of reach of children and ensure the storage environment remains within standard temperature limits.
Healthcare Collaboration: Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes and to address any clinical concerns promptly.
Disclaimer: Faslodex is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.
